KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

NASDAQ · Instruments & Medical Devices · Surgical & Medical Instruments & Apparatus

Price
$24.77
Day
+1.39%
Market cap
$1.48B

Close 2026-09-21.

The company

Our Platform Building on this foundation, the Cardiac Recovery System platform includes a suite of digital and clinical support solutions designed to provide a more connected approach to patient management. Integrated solutions—including the ASSURE patient application, Kestra CareStation ® remote patient management platform, Heart Alert Services, and ASSURE Assist ® —provide clinicians with greater visibility into patient status and support informed care decisions. The ASSURE patient application engages patients through real-time mobile connectivity and facilitates communication between patients and healthcare providers. Our Strategy We believe the continued growth of our company will be driven by the following success factors : • Large, growing, and underpenetrated WCD market; • Highly innovative Cardiac Recovery System platform designed to protect patients from SCA and improve patient compliance and healthcare provider adoption; • Comprehensive and fully integrated suite of mission critical digital solutions and services for driving patient and healthcare provider engagement; • Material investments in infrastructure to support rapid growth and scale; • Established reimbursement and favorable payor coverage; • Strong and compelling body of clinical evidence; • Broad research and development capabilities and a robust intellectual property portfolio; and • Highly experienced management team and board with proven commercial growth success.

From Item 1: Our Platform · Our Strategy.

Institutional holders

Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.

Insider trades

Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.

Recent filings